Pharmaceutical industry news
Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.
35,074 stories, page 63 of 585
๐บ๐ธResearchclinicaltrials.gov
NCT07391774: Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Study type: INTERVENTIONAL. Phase: PHASE3.
ClinicalTrials.govOriginal source
๐บ๐ธResearchclinicaltrials.gov
NCT06899633: Multicenter, Observational, Descriptive Study of the Diagnosis, Course and Treatment of Patients With SLE in Routine Practice in Kazakhstan: a Registry Study With Retrospective and Prospective Components.
Study type: OBSERVATIONAL. Phase: .
ClinicalTrials.govOriginal source
๐บ๐ธResearchclinicaltrials.gov
NCT05985954: Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy
Study type: INTERVENTIONAL. Phase: PHASE1.
ClinicalTrials.govOriginal source
๐บ๐ธResearchclinicaltrials.gov
NCT05920356: A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Study type: INTERVENTIONAL. Phase: PHASE3.
ClinicalTrials.govOriginal source
๐บ๐ธResearchclinicaltrials.gov
NCT05206357: Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab
Study type: INTERVENTIONAL. Phase: PHASE1.
ClinicalTrials.govOriginal source
๐บ๐ธResearchclinicaltrials.gov
NCT05201248: A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab As Monotherapy or Combined With Standard of Care Therapies in Adult Participants in China With B-Cell Non-Hodgkin Lymphoma
Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.
ClinicalTrials.govOriginal source
๐บ๐ธResearchclinicaltrials.gov
NCT05081609: A Study to Investigate Safety and Tolerability of TransCon IL-2 ฮฒ/ฮณ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies
Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.
ClinicalTrials.govOriginal source